Cargando…

Mitochondrial DNA variation in Parkinson’s disease: Analysis of “out-of-place” population variants as a risk factor

Mitochondrial DNA (mtDNA), a potential source of mitochondrial dysfunction, has been implicated in Parkinson’s disease (PD). However, many previous studies investigating associations between mtDNA population variation and PD reported inconsistent or contradictory findings. Here, we investigated an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller-Nedebock, Amica C., Pfaff, Abigail L., Pienaar, Ilse S., Kõks, Sulev, van der Westhuizen, Francois H., Elson, Joanna L., Bardien, Soraya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330142/ https://www.ncbi.nlm.nih.gov/pubmed/35912088 http://dx.doi.org/10.3389/fnagi.2022.921412

Ejemplares similares

Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology
por: Cuttler, Katelyn, et al.
Publicado: (2022)

Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
por: Pfaff, Abigail L., et al.
Publicado: (2021)

Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson's disease and healthy control fibroblasts
por: Abrahams, Shameemah, et al.
Publicado: (2021)

An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
por: Pfaff, Abigail L., et al.
Publicado: (2020)

Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
por: Fröhlich, Alexander, et al.
Publicado: (2023)

Mitochondrial DNA population variation is not associated with Alzheimer’s in the Japanese population: A consistent finding across global populations
por: Wong, Johanna, et al.
Publicado: (2022)

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
por: Müller-Nedebock, Amica C., et al.
Publicado: (2023)

Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson's Disease Patients
por: Haylett, William, et al.
Publicado: (2016)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
por: Koks, Sulev, et al.
Publicado: (2021)

Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome
por: Koks, Sulev, et al.
Publicado: (2021)

Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
por: Pfaff, Abigail L., et al.
Publicado: (2022)

A Genome-Wide Screen for the Exonisation of Reference SINE-VNTR-Alus and Their Expression in CNS Tissues of Individuals with Amyotrophic Lateral Sclerosis
por: Pfaff, Abigail L., et al.
Publicado: (2023)

TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants
por: Venter, Marianne, et al.
Publicado: (2019)

Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus
por: Fröhlich, Alexander, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease
por: Gorecki, Anastazja M., et al.
Publicado: (2020)

The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Variable number tandem repeats – Their emerging role in sickness and health
por: Marshall, Jack NG, et al.
Publicado: (2021)

CRISPR deletion of a SINE-VNTR-Alu (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the MAPT locus
por: Fröhlich, Alexander, et al.
Publicado: (2023)

The aetiology of cardiovascular disease: a role formitochondrial DNA?
por: Marianne, Venter, et al.
Publicado: (2018)

Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson’s disease
por: Pienaar, Ilse S., et al.
Publicado: (2015)

Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
por: Proctor, Carole J, et al.
Publicado: (2012)

Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
por: Burns, Jessica, et al.
Publicado: (2023)

Genomics of Wolfram Syndrome 1 (WFS1)
por: Kõks, Sulev
Publicado: (2023)

A case for genomic medicine in South African paediatric patients with neuromuscular disease
por: Raga, Sharika V., et al.
Publicado: (2022)

Smoking-related general and cause-specific mortality in Estonia
por: Kõks, Gea, et al.
Publicado: (2017)

Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s Disease
por: Pillay, Nikita Simone, et al.
Publicado: (2022)

Transcriptional Basis of Psoriasis from Large Scale Gene Expression Studies: The Importance of Moving towards a Precision Medicine Approach
por: Krishnan, Vidya S., et al.
Publicado: (2022)

Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
por: Dekker, Marieke C. J., et al.
Publicado: (2020)

Sex differences in Parkinson’s disease
por: Gillies, Glenda E., et al.
Publicado: (2014)

Out of place : a memoir /
por: Said, Edward W.
Publicado: (1999)

Genome-Wide Differential Transcription of Long Noncoding RNAs in Psoriatic Skin
por: Stacey, Valerie M., et al.
Publicado: (2023)

Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin
por: Planken, Anu, et al.
Publicado: (2017)

Comparison of the Metabolic Syndrome Risk in Valproate-Treated Patients with Epilepsy and the General Population in Estonia
por: Rakitin, Aleksei, et al.
Publicado: (2014)

Changes in the Peripheral Blood Gene Expression Profile Induced by 3 Months of Valproate Treatment in Patients with Newly Diagnosed Epilepsy
por: Rakitin, Aleksei, et al.
Publicado: (2015)

Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
por: du Plessis, Stefan, et al.
Publicado: (2020)

Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
por: Kurvits, Lille, et al.
Publicado: (2019)

RNA‐sequencing of WFS1‐deficient pancreatic islets
por: Ivask, Marilin, et al.
Publicado: (2016)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Altered motor, anxiety-related and attentional task performance at baseline associate with multiple gene copies of the vesicular acetylcholine transporter and related protein overexpression in ChAT::Cre+ rats
por: Mantanona, Craig P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1t7o4rbf67kc8kh0lbq8bcqesf